Physalin F Inhibits Cell Viability and Induces Apoptosis in Non-small Cell Lung Cancer Cells

Physalin F suppresses NSCLC cell growth via PI3K/AKT and RAS/MAPK signaling pathways. These findings suggest that physalin F holds potential as an effective therapeutic agent for NSCLC harboring both wild-type and mutant EGFR.